Bispecific molecular agents that induce proximity between two proteins are an emerging paradigm of pharmaceutical intervention into biology and medicine . Targeted degradation compounds, classified as PROTACs or molecular glues, have shown great promise as a new class of chemical probes to study biology and therapeutics for treatment of disease .